Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126827 · ClinicalTrials.gov registry record · NA
Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT01126827: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01126827 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126827, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the efficacy of mindfulness-based cognitive-behavior therapy (MBCT) for improvement of symptoms associated with bipolar disorder, by comparing MBCT to supportive psychotherapy. Patients who participate in this study will be randomly assigned to receive either 1. state of the art group MBCT, or 2. supportive group psychotherapy (which is considered part of the standard care available to patients at MGH).
Interventions
- BEHAVIORAL Mindfulness-Based Cognitive Behavioral Therapy or Supportive Psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01126827
The ClinicalTrials.gov registry entry for NCT01126827 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness-Based Cognitive Behavioral Therapy or Supportive Psychotherapy is the first listed.
NCT01126827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01126827 about?
NCT01126827 is a clinical study titled "Mindfulness-Based Cognitive Behavior Therapy for Bipolar Disorder". The purpose of the study is to investigate the efficacy of mindfulness-based cognitive-behavior therapy (MBCT) for improvement of symptoms associated with bipolar disorder, by comparing MBCT to supportive psychotherapy. Patients who participate in this study will be randomly assigned to receive eith...
What is the current status of trial NCT01126827?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2010-01. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01126827?
The interventions under investigation include: Mindfulness-Based Cognitive Behavioral Therapy or Supportive Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01126827?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.